Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

4.1.2.48: low-specificity L-threonine aldolase

This is an abbreviated version!
For detailed information about low-specificity L-threonine aldolase, go to the full flat file.

Word Map on EC 4.1.2.48

Reaction

L-allo-threonine
=
glycine
+
acetaldehyde

Synonyms

GLY1, GlyA, L-TA, L-threonine aldolase, low specificity L-TA, low specificity threonine aldolase, Low-specificity L-threonine aldolase, LTA, LtaE, serine hydroxy-methyl transferase, SHMT, threonine aldolase

ECTree

     4 Lyases
         4.1 Carbon-carbon lyases
             4.1.2 Aldehyde-lyases
                4.1.2.48 low-specificity L-threonine aldolase

Engineering

Engineering on EC 4.1.2.48 - low-specificity L-threonine aldolase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D176E
500fold decrease in catalytic efficiency
D95C
less than 10% of catalytic efficiency of wild-type
D95H/E96G
less than 10% of catalytic efficiency of wild-type
D95L
less than 10% of catalytic efficiency of wild-type
D95M
less than 5% of catalytic efficiency of wild-type
D95N/E96S
less than 5% of catalytic efficiency of wild-type
D95W
less than 2% of catalytic efficiency of wild-type
D95Y
less than 5% of catalytic efficiency of wild-type
D95Y/E96T
less than 10% of catalytic efficiency of wild-type
D176E
-
500fold decrease in catalytic efficiency
-
D95C
-
less than 10% of catalytic efficiency of wild-type
-
D95L
-
less than 10% of catalytic efficiency of wild-type
-
D95M
-
less than 5% of catalytic efficiency of wild-type
-
D95Y
-
less than 5% of catalytic efficiency of wild-type
-
H126F
-
300% of wild-type activity,reduced preference for the erythro-substrate
H126N
-
60% of wild-type activity
H83F
-
less than 1% of wild-type activity, reduced preference for the erythro-substrate
H83F/H126F
H83N
-
less than 10% of wild-type activity
industry
biocatalysis using threonine aldolases opens up a way to synthesise beta-hydroxy-alpha-amino acids in one step. Dichiral beta-hydroxy-alpha-amino acids are a highly valuable class of compounds from which pharmaceutically active intermediates for the synthesis of e.g. beta-sympathomimetic drugs. Methods to immobilise the L-low specificity threonine aldolase of Escherichia coli are studied. The entrapment of the enzyme into a porous network of orthosilicate appears to be the most promising method
K222A
synthesis
biocatalysis using threonine aldolases opens up a way to synthesise beta-hydroxy-alpha-amino acids in one step. Dichiral beta-hydroxy-alpha-amino acids are a highly valuable class of compounds from which pharmaceutically active intermediates for the synthesis of e.g. beta-sympathomimetic drugs. Methods to immobilise the L-low specificity threonine aldolase of Escherichia coli are studied. The entrapment of the enzyme into a porous network of orthosilicate appears to be the most promising method
F87A
-
no change in the ration of cleavage of L-threonine to L-allo-threonine
-
F87D
-
mutation doubles the preference of the enzyme for L-allo-threonine
-
H126F
-
300% of wild-type activity,reduced preference for the erythro-substrate
-
H126N
-
60% of wild-type activity
-
K222A
-
slight decrease in kcat and slight increase in Km values for both L-threonine and L-allo-threonine
-
K207A
the mutant enzyme shows no detectable enzyme activity. The mutant enzyme show the disappearance of the absorption maximum at 420 nm, indicating that the Schiff base linkage between the epsilon-amino group of the active-site lysine residue and the pyridoxal 5'-phosphate cofactor aldehyde group of the wild type is not present in the mutant enzyme
K207R
the mutant enzyme shows a specific activity of about 1000 times lower than that of the wild-type enzyme. The mutant enzyme show the disappearance of the absorption maximum at 420 nm, indicating that the Schiff base linkage between the epsilon-amino group of the active-site lysine residue and the pyridoxal 5'-phosphate cofactor aldehyde group of the wild type is not present in the mutant enzyme
K207A
-
the mutant enzyme shows no detectable enzyme activity. The mutant enzyme show the disappearance of the absorption maximum at 420 nm, indicating that the Schiff base linkage between the epsilon-amino group of the active-site lysine residue and the pyridoxal 5'-phosphate cofactor aldehyde group of the wild type is not present in the mutant enzyme
-
K207R
-
the mutant enzyme shows a specific activity of about 1000 times lower than that of the wild-type enzyme. The mutant enzyme show the disappearance of the absorption maximum at 420 nm, indicating that the Schiff base linkage between the epsilon-amino group of the active-site lysine residue and the pyridoxal 5'-phosphate cofactor aldehyde group of the wild type is not present in the mutant enzyme
-
A169T
-
stability-enhanced mutant, half life at 63°C is 3.7 min
D104N
-
stability-enhanced mutant, half life at 63°C is 5.8 min
F18I
-
stability-enhanced mutant, half life at 63°C is 5.0 min, the specific activity is decreased by 45% compared to the wild type enzyme
H177Y
-
stability-enhanced mutant, half life at 63°C is 14.6 min
R241C/A287V
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
V86I/R241C/Y306C
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
Y34C
-
the mutation dramatically increases the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
Y39C/Y306C
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
Y39C/Y306C/A48T
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
Y39C/Y306C/R316C
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
A169T
-
stability-enhanced mutant, half life at 63°C is 3.7 min
-
D104N
-
stability-enhanced mutant, half life at 63°C is 5.8 min
-
F18I
-
stability-enhanced mutant, half life at 63°C is 5.0 min, the specific activity is decreased by 45% compared to the wild type enzyme
-
H177Y
-
stability-enhanced mutant, half life at 63°C is 14.6 min
-
R241C/A287V
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
-
V86I/R241C/Y306C
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
-
Y34C
-
the mutation dramatically increases the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
-
Y39C/Y306C
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
-
Y39C/Y306C/A48T
-
the mutations dramatically increase the diastereoselectivity of the reverse aldol condensation activity for L-threo-3,4-dihydroxyphenylserine
-